Mysid crustaceans as standard models for the screening and testing of endocrine-disrupting chemicals

被引:51
|
作者
Verslycke, Tim
Ghekiere, An
Raimondo, Sandy
Janssen, Colin
机构
[1] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA
[2] Univ Ghent, Lab Environm Toxicol & Aquat Ecol, B-9000 Ghent, Belgium
[3] US EPA, Gulf Ecol Div, Natl Hlth & Environm Effect Res Lab, Gulf Breeze, FL 32561 USA
关键词
invertebrate; endocrine disruption; regulatory testing; standardization; Americamysis bahia;
D O I
10.1007/s10646-006-0122-0
中图分类号
Q14 [生态学(生物生态学)];
学科分类号
071012 ; 0713 ;
摘要
Investigative efforts into the potential endocrine-disrupting effects of chemicals have mainly concentrated on vertebrates, with significantly less attention paid to understanding potential endocrine disruption in the invertebrates. Given that invertebrates account for at least 95% of all known animal species and are critical to ecosystem structure and function, it remains essential to close this gap in knowledge and research. The lack of progress regarding endocrine disruption in invertebrates is largely due to: (1) our ignorance of mode-of-action, physiological control, and hormone structure and function in invertebrates; (2) lack of a standardized invertebrate assay; (3) the irrelevance to most invertebrates of the proposed activity-based biological indicators for endocrine disruptor (ED) exposure (androgen, estrogen, and thyroid); (4) limited field studies. Past and ongoing research efforts using the standard invertebrate toxicity test model, the mysid shrimp, have aimed at addressing some of these issues. The present review serves as an update to a previous publication on the use of mysids for the evaluation of EDs (Verslycke et al. 2004a). It summarizes recent investigative efforts that have significantly advanced our understanding of invertebrate-specific endocrine toxicity, population modeling, field studies, and transgeneration standard test development using the mysid model.
引用
收藏
页码:205 / 219
页数:15
相关论文
共 50 条
  • [31] Endocrine-disrupting chemicals and skin manifestations
    Qiang Ju
    Christos C. Zouboulis
    Reviews in Endocrine and Metabolic Disorders, 2016, 17 : 449 - 457
  • [32] Endocrine-Disrupting Chemicals and Disease Endpoints
    Ahn, Changhwan
    Jeung, Eui-Bae
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (06)
  • [33] The burden of endocrine-disrupting chemicals in the USA
    Andreas Kortenkamp
    Nature Reviews Endocrinology, 2017, 13 : 6 - 7
  • [34] Endocrine-disrupting chemicals and uterine fibroids
    Katz, Tiffany A.
    Yang, Qiwei
    Trevino, Lindsey S.
    Walker, Cheryl Lyn
    Al-Hendy, Ayman
    FERTILITY AND STERILITY, 2016, 106 (04) : 967 - 977
  • [35] ENDOCRINE DISRUPTORS The burden of endocrine-disrupting chemicals in the USA
    Kortenkamp, Andreas
    NATURE REVIEWS ENDOCRINOLOGY, 2017, 13 (01) : 6 - 7
  • [36] Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
    Diamanti-Kandarakis, Evanthia
    Bourguignon, Jean-Pierre
    Giudice, Linda C.
    Hauser, Russ
    Prins, Gail S.
    Soto, Ana M.
    Zoeller, R. Thomas
    Gore, Andrea C.
    ENDOCRINE REVIEWS, 2009, 30 (04) : 293 - 342
  • [37] Small fish models for identifying and assessing the effects of endocrine-disrupting chemicals
    Ankley, GT
    Johnson, RD
    ILAR JOURNAL, 2004, 45 (04) : 469 - 483
  • [38] The effect of endocrine-disrupting chemicals on placental development
    Yan, Yan
    Guo, Fengjun
    Liu, Kexin
    Ding, Rixin
    Wang, Yichao
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [39] Environmental exposure to endocrine-disrupting chemicals and miscarriage
    Krieg, Sacha A.
    Shahine, Lora K.
    Lathi, Ruth B.
    FERTILITY AND STERILITY, 2016, 106 (04) : 941 - 947
  • [40] Endocrine-disrupting chemicals and breastfeeding duration: a review
    Criswell, Rachel
    Crawford, Kathryn A.
    Bucinca, Hana
    Romano, Megan E.
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2020, 27 (06) : 388 - 395